期刊文献+

miR-455在原因不明复发性流产病人绒毛组织中表达及意义 被引量:1

Expression and significance of miR-455 in villi tissues of patients with unexplained recurrent spontaneous abortion
下载PDF
导出
摘要 目的探讨miR-455在原因不明复发性流产(URSA)病人绒毛组织中表达及意义。方法 72例URSA病人根据自然流产次数分为2~3次者(n=45)和≥4次者(n=27),同期,选取要求终止妊娠的正常早孕者40例作为对照组,留取绒毛组织,利用实时荧光定量PCR技术检测绒毛组织中miR-455、血管内皮生长因子(VEGF)和可溶性血管内皮生长因子受体-1(s Flt-1)基因表达,免疫组化SP法检测绒毛组织中微血管密度(MVD)。结果 URSA病人绒毛组织中miR-455和s Flt-1 mRNA表达量均高于对照组,而VEGF mRNA表达量低于对照组,URSA中2~3次者miR-455和s Flt-1 mRNA表达量均低于≥4次者,而VEGF mRNA表达量高于≥4次者,均差异有统计学意义(P<0.05);免疫组化结果显示,URSA病人绒毛组织中MVD为(9.9±3.2)条,低于对照组的(21.5±3.8)条,URSA中2~3次者绒毛组织中MVD为(13.4±3.1)条,高于≥4次者的(7.2±2.4)条,均差异有统计学意义(P<0.05);Pearson相关分析显示,URSA病人绒毛组织中miR-455表达量与VEGF mRNA表达量和MVD均呈负相关(r=-0.452、-0.433,P<0.05),而与s Flt-1 mRNA表达量呈正相关(r=0.539,P<0.05)。结论 miR-455在URSA病人绒毛组织中呈高表达,且与s Flt-1表达呈正相关,与VEGF表达和MVD均呈负相关,提示可能通过促进s Flt-1表达而抑制VEGF信号通路活性,从而抑制绒毛组织中血管新生。 Objective To investigate the expression and significance of miR^l55in villi tissues of patients with unexplained recurrent spontaneous abortion(URSA).Methods72cases of URSA patients were divided into2or3tim es(n=45)group and^4tim es(n=27)group according to the natural frequency of abortion.Over the same period,40cases of the normal pregnancy of terminate were selected as the control group.The expressions of miR^l55,VEGF and sFlt-l genes in villi tissues were detected by real-time PCR technology.The MVD in villi tissues was tested by immunohistochemical SP method.Results The expression levels of m iR455and sFlt-l mRNA in villus tissues of URSA patients were higher than the control group,while the expression levels of VEGF mRNA were lower than the control group.The expression levels of miR^l55and sFlt-l mRNA in villus tissues of2to3times URSA patients were lower than the^4times,while the expression levels of VEGF mRNA were higher than the^4times.The differences were statistically significant^P<0.05).The results of immunohistochemistry showed that the MVD in villi tissues of URSA patients w as(9.9±3.2),which was lower than(21.5±3.8)in the control group.The MVD of2to3times URSA patients was(13.4±3.1),which was higher than(7.2±2.4)in the^4times.The differences were statistically significant(P<0.05).Pearson correlation analysis showed that the expression levels of miR^l55in villi tissues of URSA patients were negatively correlated with the expression levels of VEGF mRNA and MVD(r=-0.452and-0.433,P<0.05),and were positively correlated with the expression levels of sFlt-1mRNA(r=0.539,P<0.05).Conclusion miR^l55was highly expressed in villus tissues of URSA patients,and was positive correlated with the expression of sFlt-1while negatively correlated with the expressions of VEGF and MVD.Suggestingthat it may inhibit the VEGF signaling pathway activity by promotings sFlt-1expression,thereby inhibiting angiogenesis in villi tissues.
作者 杨晓杰 宋俊霞 杜增利 王青 YANG Xiaojie;SONG Junxia;DU Zengli;WANG Qing(The Central Coal ( Group ) Hospital of Jiaozuo, Jiaozuo , Henan 454000 , China)
出处 《安徽医药》 CAS 2017年第8期1415-1418,共4页 Anhui Medical and Pharmaceutical Journal
基金 国家卫生计生委医药卫生科技发展基金(W2016CWHNB08)
关键词 原因不明复发性流产 imR455 血管内皮生长因子 可溶性血管内皮生长因子受体-1 Unexplained recurrent miscarriage miR-l55 Vascular endothelial growth factor Soluble vascular endothelial growth factor receptor-1
  • 相关文献

参考文献2

二级参考文献27

  • 1Cao Y, E G, Wang E, et al. VEGF exerts an angiogenesis in de- pendent function in cancer cells to promote their malignant progres- sion[J]. Cancer Res,2012,72(16) :3912 -3918.
  • 2Ding M, Fu X, Tan H, et al. The effect of vascular endothelial growth factor C expression in tumor associated macrophages on lymphangiogenesis and lymphatic metastasis in breast cancer[ J]. Mol Med Report,2012,6(5):1023- 1029.
  • 3Benedet JL, Bender H, Jones H, et al. FIGO staging classifications and clinical practice guidelines in the management of :necologic cancers. FIGO Committee On Gynecologic Oncalogy [ J ]. Int J Gyaecol Obstet,2000,70(2) :209 -262.
  • 4Chen C, Ridzon DA, Broomer A J, et al. Real - time quantification of microRNAs by stem - loop RT - PCR [ J ]. Nucleic Acids Res, 2005,33 (20) :e179.
  • 5Stamatopoulos B, Meulenmn N, Haibe Kains B, et al. microRNA - 29c and microRNA - 223 down - regulation has in vivo significance in chronic lymphocytic leukemia and improves disease risk stratifi- cation [ J ]. Blood, 2009,113 ( 21 ) :5237 - 5245.
  • 6Molhoek KR, (,riesemann tl, Shu J. ltuman melanoma cytolysis by combined inhibition of" mammalian target of rapamycin anti vascular endothelial growth factor/vascular endothelial growth factor- 2 [ J ]. Cancer Res,2008,68 (110) :4392 - 4397.
  • 7lorio MV,Croce CM. MicroRNA dysregulation in cancer: diagnos- tics ,monitoring and therapeutics. A comprehensive review[ J]. EM- BO Mol Med,2012,4(3) :143 -159.
  • 8Iorio MV, Croce CM. Causes and consequences of MicroRNA dys- regulation [ J ]. Cancer J,2012,18 ( 3 ) :215 - 222.
  • 9Sand M, Skrygan M, Sand D, et al. Expression of microRNAs in basal cell carcinoma[ J]. Br J Dermatol,2012 ,4 :27.
  • 10Roybal JD,Zang Y, Ahn YH, et al. miR -200 inhibits lung ade- nocarcinoma ceil invasion and metastasis by targeting Fltl/VEG- FR1 Fltl/VEGFR1 [J]. Mol Cancer Res,2011,9( 1 ) :25 -35.

共引文献5

同被引文献13

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部